Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5687 of 5804
-
New drug CLYM116 enters first human safety trial
Knowledge-focused Recruiting nowThis Phase 1, first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CLYM116 in healthy volunteers.
Phase: PHASE1 • Sponsor: Climb Bio, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Study on anesthesia and Pre-Surgery anxiety withdrawn before starting
Knowledge-focused TerminatedThis prospective, cross-sectional study aims to investigate the impact of planned anesthesia technique (general or regional anesthesia) and patients' previous anesthesia experience on preoperative anxiety in patients undergoing upper extremity surgery. The secondary objective is …
Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New exosome drug tested in humans for first time – safety first
Knowledge-focused Recruiting nowThe investigational drug, SOB100, is an HLA-G targeted exosome equipped with a nanobody namely anti-HLA-G VHH on the exosome membrane. This is a Phase I dose escalation study to exam the tolerability, safety, and pharmacokinetics in healthy subjects.
Phase: PHASE1 • Sponsor: Shine-On Biomedical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Contact lens stress test for fuchs dystrophy eyes
Knowledge-focused TerminatedThe purpose of this study is to determine the difference in the cornea's response to contact lens placement between healthy and unhealthy eyes. The amount of corneal swelling (corneal thickness) between normal and FECD patients before and after a stress test will be measured and …
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Breath-Testing backpack trial for cystic fibrosis pulled before start
Knowledge-focused TerminatedCystic fibrosis (CF) is the most common autosomal recessive disease that leads to early mortality in Caucasians and affects around 7500 patients in France. Progression of the disease depends on pulmonary exacerbations defined as acute deterioration of respiratory symptoms which u…
Phase: NA • Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New digital eye test in turkish put to the test
Diagnosis Not yet recruitingThe goal of this observational methodological study is to validate the Turkish version of the DDIVAT visual acuity measuring device in a Turkish-speaking adult population. The main questions it aims to answer are: Does the Turkish version of the DDIVAT provide reliable and vali…
Sponsor: Trakya University • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Chemsex therapy trial pulled before enrolling a single person
Knowledge-focused TerminatedQuasi-randomized control trial of acceptance and commitment therapy (ACT) for chemsex.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Dry eye drug combo safety trial pulled before it started
Disease control TerminatedA Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease
Phase: PHASE3 • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Pen or syringe? study tests easier pasireotide delivery
Knowledge-focused CompletedThis single-center Phase 1 study in healthy male and female subjects of 18 to 55 years (inclusive) will follow an open-label, randomized, single-dose, crossover design with 2 intervention periods. The purpose of this study is to assess and compare the pharmacokinetic characterist…
Phase: PHASE1 • Sponsor: RECORDATI GROUP • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Schizophrenia offender drug study pulled before it started
Knowledge-focused TerminatedConsidering the vulnerability of patients with schizophrenia in forensic treatment, we have designed a prospective-observational trial. The purpose of our study, notably its focus on selecting the appropriate medication, developing clinical profiles, and determining the grounds o…
Sponsor: Psychiatric University Hospital, Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Sleep study after nose surgery cancelled before starting
Knowledge-focused TerminatedThis prospective observational study aims to evaluate the association between routinely applied anesthesia techniques and postoperative sleep quality in adult patients undergoing septoplasty. Patients will receive either total intravenous anesthesia or inhalational anesthesia acc…
Sponsor: Elazıg Fethi Sekin Sehir Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Healthy volunteers test new drug combinations in Early-Stage trial
Knowledge-focused Recruiting nowThis study aims to evaluate the safety and pharmacokinetic characteristics of DWJ1622, DWC202313, and DWC202314 in healthy adult volunteers under fed conditions.
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New drug interaction study launches in healthy volunteers
Knowledge-focused Recruiting nowDrug-Drug Interaction between DW4421 and three different kinds of NSAIDs
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New program aims to tackle diabetes in people with mental illness – but study never started
Disease control TerminatedThe goal of this clinical trial is to examine if it is feasible to randomly assign people into two groups and participate in Lifestyle MIND (Mental Illness and/N' Diabetes) at two different times. Lifestyle MIND is a diabetes lifestyle intervention recently developed for people w…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New gadget could replace messy bite paper at the dentist
Diagnosis ENROLLING_BY_INVITATIONthis study will test the ability of the Jaw Tracking Device to detect occlusal contacts as an additional data that could be used during diagnosis and occlusion analysis and the results will be compared to contacts gotten from articulating paper and that will be tested at differen…
Phase: NA • Sponsor: Cairo University • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Shoulder pain exercise trial pulled before it began
Symptom relief TerminatedUpper limb tendinopathies, especially the so called "shoulder impingement syndrome", is a common injury among the population. Its management usually involves active treatments, being the therapeutic progressive exercise the most important and effective modality. However, whether …
Phase: NA • Sponsor: University of Malaga • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Study on money and addiction recovery pulled before starting
Knowledge-focused TerminatedThe goal of this study is to provide a scientific understanding of the impact of socioeconomic status (SES) on the recovery trajectory (psychosocial functioning, relapse/remission status, and neurocognitive mechanisms).
Sponsor: Virginia Polytechnic Institute and State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Fibromyalgia pain device study pulled before it even started
Symptom relief TerminatedThis is study designed to confirm the effectiveness of the Sana Device in patients with pain due to fibromyalgia on quality of life as measured by the Fibromyalgia Impact Questionnaire Revised (FIQR). It is a two arm study in which subjects will be randomly assigned to either act…
Phase: NA • Sponsor: Sana Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
CAR-T therapy's long-term brain effects to be studied
Knowledge-focused TerminatedThis study aims to assess the feasibility of performing neuropsychological testing to measure the cognitive performance of individuals following Axicabtagene ciloleucel CAR-T therapy at Stanford.
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Quit smoking with a custom avatar: new app targets LGBTQ+ youth
Symptom relief TerminatedThis clinical trial assesses the acceptability and efficacy of Empowered, Queer, Quitting, and Living--New Mexico (EQQUAL-NM), a smoking cessation intervention for sexual and gender minority young adults in New Mexico. Smoking prevalence among sexual and gender minority (SGM) adu…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC